Health Canada has approved a second generic version of Ozempic, produced by Canadian firm Apotex, just days after clearing the first generic from India’s Dr. Reddy’s Laboratories. The move could ...
Hosted on MSN
Canada approves second generic Ozempic as use surges
Health Canada has approved a second generic version of semaglutide, the active ingredient in Ozempic, with Toronto-based Apotex set to launch it within weeks. The move comes amid rapidly rising GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results